8-K: Shuttle Pharmaceuticals Executes 1:10 Reverse Stock Split

Shuttle Pharmaceuticals Holdings, Inc. has implemented a 1-for-10 reverse stock split effective June 11, 2026, to adjust its common stock structure.

Summary

• The company implemented a 1-for-10 reverse stock split of its common stock.
• The action was approved by stockholders at the annual meeting on May 21, 2026.
• The reverse split became effective at the start of trading on June 11, 2026.
• Every 10 shares of pre-split common stock were combined into 1 share of post-split common stock.
• The total number of authorized shares remains unchanged.
• Fractional shares are rounded up to the nearest whole share.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral-to-negative event; while it addresses technical listing compliance, it highlights the underlying pressure on the company's share price.

Positives

• The reverse stock split may help the company maintain compliance with Nasdaq listing requirements regarding minimum bid price.

Negatives

• Reverse stock splits are often perceived by the market as a sign of financial distress or a declining share price.
• The action reduces the liquidity of the stock by decreasing the total number of shares outstanding.

Risks

• Potential negative market perception associated with reverse stock splits.
• Risk of continued downward pressure on share price despite the consolidation of shares.
• Potential for volatility in trading following the implementation of the split.

Future Outlook

The company intends to continue trading on The Nasdaq Capital Market on a post-split adjusted basis, with the primary goal of maintaining listing compliance.

Management Comments

• The Board of Directors exercised its discretion to effect the reverse stock split following authorization from stockholders.

Industry Context

StockSavvy.ai notes that reverse stock splits are a common, albeit often defensive, maneuver for small-cap biotech firms listed on Nasdaq to avoid delisting due to sub-$1.00 share price requirements.

Comparison to Industry Standards

• The 1:10 ratio is consistent with standard practices for micro-cap companies seeking to boost share price to meet exchange listing thresholds.
• The use of rounding up fractional shares to a whole share is a standard shareholder-friendly practice in such corporate actions.

Corporate Governance

Stakeholder Impact

• Shareholders will see a reduction in the number of shares held, offset by a proportional increase in the price per share.
• Holders of warrants and convertible securities will see proportional adjustments to exercise/conversion prices.

Next Steps

• VStock Transfer LLC will notify stockholders of record regarding the split.
• Trading continues on Nasdaq under the new CUSIP 825693500.

Key Dates

Recommendation

The reverse split is a technical adjustment to maintain listing status and does not fundamentally change the company's valuation or business prospects; investors should wait for operational milestones before adjusting positions.

Keywords

Shuttle Pharmaceuticals, SHPH, Reverse Stock Split, Nasdaq, Corporate Action, Stock Consolidation